GLP-1 agonists, short for glucagon-like peptide-1 agonists, are a class of medications used primarily in the treatment of type 2 diabetes. These drugs act similarly to the natural hormone GLP-1, which regulates blood sugar. GLP-1 agonists stimulate insulin release in response to high blood sugar levels, lowering blood glucose. They also slow gastric emptying and decrease glucagon secretion, which aids in blood sugar control. A notable benefit of GLP-1 agonists is their potential to promote weight loss, making them a favorable choice for patients with diabetes and obesity. They are typically administered via injection and are known for their role in improving glycemic control. They have a low risk of causing hypoglycemia when used without other glucose-lowering drugs that can cause low blood sugar.